Exhibit Hall Hours & Passes
Exhibit hall only passes can purchased onsite for $100 per day, and the exhibit hall will be open on March 20-21 during the following hours:
- Tuesday, March 20, 2018: 9:15am - 7:15pm
- Wednesday, March 21, 2018: 9:15am - 3:45pm
To purchase a pass, please proceed to the registration desk located on the 2nd floor of the Hilton San Francisco Union Square. Main conference passes may also be purchased onsite.
BREAK DOWN SILOS ACROSS DEPARTMENTS
The BPI West 2018 agenda is comprised of four phase-based tracks, designed to bring attendees working across multiple departments together to collectively share challenges and discuss the solutions needed to improve the speed, lower the cost and increase the quality of biologics development.
EARLY STAGE PROCESS DEVELOPMENT TRACK
Advance promising biologics from early stage process development to IND by learning how industry leaders reduce timelines, lower costs, develop robust cell lines, and utilize new technologies in downstream processing.
LATE STAGE PROCESS DEVELOPMENT TRACK
Ensure your product is ready for market launch by applying global best practices for process validation, raw material sourcing, process robustness, process simplification and scale-up manufacturing.
COMMERCIAL MANUFACTURING TRACK
Create a sustainable commercial manufacturing program by applying innovating strategies for capacity improvements, supply chain continuity, lifecycle management and operational efficiencies.
SINGLE-USE/ FLEXIBLE FACILITIES TRACK
Accelerate development for multi-product pipelines, global markets and capacity optimization by meeting requirements for validation, supply chain, design and operational considerations.
BPI West 2018 Keynote Speakers
Accelerating Development and Innovation: Advances & Challenges Using Examples from Vaccine Development
Tony D’Amore, Ph.D., MBA, Vice President, Product Research and Development, Sanofi Pasteur
Process Development and Manufacturing of Autologous Cell Therapy Products
Vijay Chiruvolu, Vice President, Process Sciences and Engineering, Kite Pharma, Inc.
Post Approval Changes and How to Navigate the Regulatory Requirements
Arulvathani Arudchandran, Ph.D., Microbiologist, FDA-CDER
California Life Sciences State of the Industry 2018
Sara Radcliffe, President and CEO, California Life Sciences Association
GAIN THE SCIENCE, TECHNOLOGIES AND CONTACTS YOU NEED TO ACCELERATE BIOLOGICS TO MARKET
THE LEADING SCIENCE
The scientific agenda offers 100+ speaker presentations designed to improve the speed, cost and quality of your process development and manufacturing efforts.
Our large, multi-track format presents innovative scientific developments, industry updates and technology applications across the entire bioprocessing spectrum from early stage process development through commercial launch preparation.
THE MOST INNOVATIVE TECHNOLOGY
The exhibit hall gathers 80+ exhibitors representing global CMOs, CROs, suppliers and technology leaders who can help your company accelerate your product to market.
See live product demonstrations and discuss your needs with knowledgeable vendors from all over the world.
THE RIGHT PARTNERS FOR YOU
Whether you are looking to meet potential customers or partners, BPI West is the one-stop shop to network with global scientists and decision makers working across all aspects of the biopharmaceutical field.
Attendee luncheons, poster viewing hours and evening cocktail receptions offer simple yet effective networking opportunities. Plus, your registration includes access to the BPI West app, allowing you to view the entire attendee list and schedule meetings before, during and after the event.
Continuous Processing: Early and Late Stage Process Development
Innovations Leading to Simplification, Cost Reduction, and Cost-Modeling
Introduction and Innovations in Cell & Gene Therapies
ADVANCE WITH TRANSFORMATIVE SOLUTIONS
Sponsored content is provided by GE
Explore productivity and flexibility in an interactive manufacturing environment and see for yourself how quickly we can address your capacity needs. Join us during our GE Healthcare Life Science sponsored presentations, technology workshops, and poster
Reimagine capacity in booth #307
Emerging Therapies Featured Report
According to a 2017 industry report, 74% of biopharmaceuticals currently in development (phase 1–3) are possible first-in-class medicines. They include regenerative medicines, conjugated monoclonal antibodies (MAbs), and DNA and RNA therapeutics. Some emerging therapies — such as antibody–drug conjugates (ADCs) and biobetters — have been more at the forefront of discussions than others, but all are poised to bring exciting changes to patient care. Authors and experts in this Featured Report discuss how meeting and optimizing specific process needs for those products will be imperative to keep pace with innovation.
Thank you to the BPI West 2018 Advisory Board
With the help of our outstanding advisory board below, the BPI West 2018 agenda includes many of the brightest minds in bioprocessing to keep you up-to-date on industry trends and challenges across the entire bioprocessing spectrum.
David Brindley, Ph.D., Senior Research Fellow, University of Oxford
David Brühlmann, Ph.D., Manager, Biotech Process, Merck
Hanmin Dong, Senior Scientist I, Abbvie Biotherapeutics Inc.
Sabine Gaillard, Ph.D., Scientist, Bioprocess Research & Development, Sanofi Pasteur
Jente Lu, Ph.D., Senior Scientist I, BioMarin Pharmaceuticals
Jeffrey Guss, Automation/Informatics Engineer, GSK
Padmadhar Madupu, Manager Process Engineering & Development, Pfizer
Shawn Liu PhD, Chief Scientist & Department Head, Bayer
Sourav Kundu Ph.D., Sr Director, Process Development, TEVA
Yuyi Shen Ph.D., Senior Process Expert, Grifols
Arnie Horowitz Ph.D., retired from Xoma, Consultant
Ashley Hesslein, Ph.D., Associate Director, Bayer
Ali Ghoorchian, Ph.D., Senior Scientist II, Manufacturing Science and Technology, Pfizer
Sigma Mostafa, Ph.D., Vice President, Process Development, KBI Biopharma, Inc.
Nobel Vale, Research Scientist, Analytical & BioanalyticalDevelopment, Bristol-Myers Squibb
Kyle Zingaro, Ph.D., Development Scientist II, Early Stage Process Development, Alexion Pharmaceuticals, Inc.
"This conference brings together leading researchers in biopharma along the entire lifecycle of products. It is an important venue for sharing of key information and moving the field forward."
Gargi Haheshwari, Ph.D.
Executive Director, Biologics Process Development & Commercialization,
"Sharing experiences helps us as individuals, but also projects, companies and the industry, ultimately leading to better drugs for patients."
Mark R.H. Krebs, Ph.D.
Senior Scientist, Technical Development
"BPI West is an ideal meeting to share experiences with industry leaders in the bioprocess field."
William N. Napoli
Scientist, BioProcess Technology and Expression, BioProcess Development
Merck & Co., Inc.
Thank you to our media partners.